Ohashi Hiroshige, Oda Hiroshi, Ohno Michiya, Mori Urara
Division of Nephrology, Prefectural Gifu Hospital.
Clin Calcium. 2004 Jun;14(6):123-9.
The field of cardiovascular disease in patients with dialysis has seen a tremendous increase in the number and diversity of diagnostic techniques available. Therefore, the newer methods have added new types of information to our diagnostic area. The plain chest roentgenogram and electrocardiogram are still simple and important tests. The other noninvasive procedures such as echocardiography, radionuclide techniques, CT and MRI supply important additional information concerning cardiac anatomy and function, but invasive cardiac catheterization remains the only method for accurately measuring intracardiac pressures and cineangiography is still necessary for defining the anatomy of the coronary arteries. Recently, the determination of natriuretic peptides (ANP,BNP), noradrenaline and troponin is added to evaluate cardiac function. The purpose of this paper discusses the use of these techniques in patients with dialysis.
在透析患者的心血管疾病领域,可用诊断技术的数量和种类大幅增加。因此,这些更新的方法为我们的诊断领域增添了新的信息类型。胸部X线平片和心电图仍然是简单而重要的检查。其他非侵入性检查,如超声心动图、放射性核素技术、CT和MRI,提供了有关心脏解剖结构和功能的重要补充信息,但侵入性心脏导管检查仍然是准确测量心内压力的唯一方法,而冠状动脉造影对于明确冠状动脉解剖结构仍然是必要的。最近,利钠肽(ANP、BNP)、去甲肾上腺素和肌钙蛋白的测定也被用于评估心脏功能。本文旨在探讨这些技术在透析患者中的应用。